Core Insights - Renovaro Inc. has appointed Nathen Fuentes as Chief Financial Officer effective January 2, 2025, replacing interim CFO Simon Tarsh [1][2] - Fuentes brings extensive experience in biotechnology and specialty healthcare, having held senior financial leadership roles and led acquisition and organic growth initiatives [2][3] - The company aims to revolutionize healthcare through advanced diagnostics and personalized immunotherapy for cancer patients [3][4] Company Overview - Renovaro focuses on accelerating precision and personalized medicine for longevity, utilizing AI and biotechnology for early diagnosis, targeted treatments, and drug discovery [4] - The company includes RenovaroBio, which specializes in advanced cell-gene immunotherapy, and RenovaroCube [4]
Renovaro Appoints Nathen Fuentes as Chief Financial Officer